Article
IVAX Corp. joins the growing number of drug manufacturers to market its version of brimonidine tartrate ophthalmic solution 0.2%.
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.